---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-092471"
form_type: "8-K"
ticker: "ESLA"
cik: "0001844417"
company_name: "Estrella Immunopharma, Inc."
filed_at: "2025-09-26T23:59:59+00:00"
generated_at: "2026-05-17T05:36:15.396751+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# Estrella Immunopharma appoints Jia Dengyao to Board of Directors

## Summary
- Board appointed Jia Dengyao as director effective September 22, 2025.
- Mr. Jia has not been named to any Board committees as of the filing.
- Company entered into standard indemnification agreement with new director.
- Appointment adds a new independent voice but no other details provided.

## SEC filing metadata
- accession: 0001213900-25-092471
- form_type: 8-K
- ticker: ESLA
- cik: 0001844417
- company_name: Estrella Immunopharma, Inc.
- filed_at: 2025-09-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844417/000121390025092471/0001213900-25-092471-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844417/000121390025092471/ea0259031-8k_estrella.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-092471
- JSON: https://secwatch.observer/filing/0001213900-25-092471.json
- Plain text: https://secwatch.observer/filing/0001213900-25-092471.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.